GLP-1 receptor agonists frequently cause nausea, vomiting, and diarrhea, especially during treatment initiation
Your prescribing clinician can access the latest safety summaries to contextualize your individual risk profile
doi: 10.1104/pp.104.058917
Because MT-I only targets MC1R, it produces tanning without the sexual side effects, appetite changes, or nausea associated with MT-II
Interestingly, a recent study proposed novel early secretory phase-specific markers showing that epithelial cell differentiation is not yet completed during this phase, with luminal and glandular cells remaining in a pre-luminal and pre-glandular state, respectively [25]
Exendin 939 did not affect proton-induced TRPV1 activation, suggesting its selective antagonism